141 related articles for article (PubMed ID: 11891465)
21. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
[TBL] [Abstract][Full Text] [Related]
22. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
23. p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
Samnick S; Romeike BF; Kubuschok B; Hellwig D; Amon M; Feiden W; Menger MD; Kirsch CM
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):532-41. PubMed ID: 14722685
[TBL] [Abstract][Full Text] [Related]
24. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
[TBL] [Abstract][Full Text] [Related]
25. Sequential scintigraphic strategy for the differentiation of brain tumours.
Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
[TBL] [Abstract][Full Text] [Related]
26. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.
Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Samnick S; Maasjosthusmann U; Lerch H; Gildehaus FJ; Wassmann H; Schober O
Eur J Nucl Med; 1996 Oct; 23(10):1345-53. PubMed ID: 8781139
[TBL] [Abstract][Full Text] [Related]
27. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
[TBL] [Abstract][Full Text] [Related]
28. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
[TBL] [Abstract][Full Text] [Related]
29. Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy.
Verburg FA; Sweeney R; Hänscheid H; Dießl S; Israel I; Löhr M; Vince GH; Flentje M; Reiners C; Samnick S
Nuklearmedizin; 2013; 52(1):36-42. PubMed ID: 23303224
[TBL] [Abstract][Full Text] [Related]
30. Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
Pike VW; Halldin C; Nobuhara K; Hiltunen J; Mulligan RS; Swahn CG; Karlsson P; Olsson H; Hume SP; Hirani E; Whalley J; Pilowsky LS; Larsson S; Schnell PO; Ell PJ; Farde L
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1520-8. PubMed ID: 14579092
[TBL] [Abstract][Full Text] [Related]
31. Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas.
Romeike BF; Hellwig D; Heimann A; Kempski O; Feiden W; Kirsch CM; Samnick S
Anticancer Res; 2004; 24(6):3971-6. PubMed ID: 15736441
[TBL] [Abstract][Full Text] [Related]
32. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.
Kuwert T; Probst-Cousin S; Woesler B; Morgenroth C; Lerch H; Matheja P; Palkovic S; Schäfers M; Wassmann H; Gullotta F; Schober O
J Nucl Med; 1997 Oct; 38(10):1551-5. PubMed ID: 9379191
[TBL] [Abstract][Full Text] [Related]
33. Presurgical identification of epileptic foci with iodine-123 iomazenil SPET: comparison with brain perfusion SPET and FDG PET.
Tanaka F; Yonekura Y; Ikeda A; Terada K; Mikuni N; Nishizawa S; Ishizu K; Okazawa H; Hattori N; Shibasaki H; Konishi J; Onishi Y
Eur J Nucl Med; 1997 Jan; 24(1):27-34. PubMed ID: 9044873
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
Henze M; Mohammed A; Mier W; Rudat V; Dietz A; Nollert J; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):324-30. PubMed ID: 12002706
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
[TBL] [Abstract][Full Text] [Related]
36. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
[TBL] [Abstract][Full Text] [Related]
38. Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects.
Fujita M; Seibyl JP; Vaupel DB; Tamagnan G; Early M; Zoghbi SS; Baldwin RM; Horti AG; KoreN AO; Mukhin AG; Khan S; Bozkurt A; Kimes AS; London ED; Innis RB
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):183-90. PubMed ID: 11926380
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
40. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography.
Almeida P; Ribeiro MJ; Bottlaender M; Loc'h C; Langer O; Strul D; Hugonnard P; Grangeat P; Mazière B; Bendriem B
Eur J Nucl Med; 1999 Dec; 26(12):1580-8. PubMed ID: 10638410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
